Silence Therapeutics management to participate in September investor conferences
Silence Therapeutics plc said management will participate in three September investor conferences, with invited investors able to join via webcast.
Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in the following conferences and invited investors to participate by webcast.The live webcast can be acces…